BR0314243A - Derivados de 4-(3,5-dicianofenoxi)pirazolo para uso como moduladores da transcriptase reversa no tratamento da i.a hiv - Google Patents

Derivados de 4-(3,5-dicianofenoxi)pirazolo para uso como moduladores da transcriptase reversa no tratamento da i.a hiv

Info

Publication number
BR0314243A
BR0314243A BR0314243-4A BR0314243A BR0314243A BR 0314243 A BR0314243 A BR 0314243A BR 0314243 A BR0314243 A BR 0314243A BR 0314243 A BR0314243 A BR 0314243A
Authority
BR
Brazil
Prior art keywords
hiv
reverse transcriptase
modulators
treatment
derivatives
Prior art date
Application number
BR0314243-4A
Other languages
English (en)
Inventor
Charles Eric Mowbary
David Anthony Price
Matthew Duncan Selby
Paul Anthony Stupple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0314243A publication Critical patent/BR0314243A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29—Saturated compounds containing keto groups bound to rings
    • C07C49/293—Saturated compounds containing keto groups bound to rings to a three- or four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29—Saturated compounds containing keto groups bound to rings
    • C07C49/327—Saturated compounds containing keto groups bound to rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"DERIVADOS DE 4-(3,5-DICIANOFENOXI)PIRAZOLO PARA USO COMO MODULADORES DA TRANSCRIPTASE REVERSA NO TRATAMENTO DA I.A HIV". Esta invenção diz respeito aos derivados de pirazolo de fórmula (I) e sais, solvatos ou derivados farmaceuticamente aceitáveis destes, a sua utilização em medicina, às formulações que os contém, aos processos para a sua preparação e aos intermediários utilizados nestes processos. Os compostos da invenção ligam-se à enzima transcriptase reversa e são moduladores, em especial inibidores, desta. A transcriptase reversa está envolvida no ciclo de vida infeccioso do Vírus da Imunodeficiência Humana (HIV). Os compostos que interferem com a função desta enzima têm mostrado utilidade no tratamento de condições provocadas pelo HIV e por retrovírus geneticamente relacionados, tal como a Síndrome da Imunodeficiência Adquirida (SIDA).
BR0314243-4A 2002-09-16 2003-09-08 Derivados de 4-(3,5-dicianofenoxi)pirazolo para uso como moduladores da transcriptase reversa no tratamento da i.a hiv BR0314243A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0221477.3A GB0221477D0 (en) 2002-09-16 2002-09-16 Chemical compounds
GBGB0223354.2A GB0223354D0 (en) 2002-09-16 2002-10-08 Chemical compounds
PCT/IB2003/003946 WO2004024147A1 (en) 2002-09-16 2003-09-08 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv

Publications (1)

Publication Number Publication Date
BR0314243A true BR0314243A (pt) 2005-07-26

Family

ID=31995706

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314243-4A BR0314243A (pt) 2002-09-16 2003-09-08 Derivados de 4-(3,5-dicianofenoxi)pirazolo para uso como moduladores da transcriptase reversa no tratamento da i.a hiv

Country Status (20)

Country Link
EP (1) EP1542679B1 (pt)
JP (1) JP2006504792A (pt)
KR (1) KR20050043962A (pt)
CN (1) CN1681494A (pt)
AP (1) AP2005003248A0 (pt)
AU (1) AU2003263422A1 (pt)
BR (1) BR0314243A (pt)
CA (1) CA2496315A1 (pt)
DE (1) DE60311284T2 (pt)
EA (1) EA200500287A1 (pt)
EC (1) ECSP055673A (pt)
GB (2) GB0221477D0 (pt)
HR (1) HRP20050222A2 (pt)
IS (1) IS7705A (pt)
MA (1) MA27435A1 (pt)
MX (1) MXPA05002963A (pt)
NO (1) NO20051833L (pt)
OA (1) OA12920A (pt)
PL (1) PL375976A1 (pt)
WO (1) WO2004024147A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005100322A1 (en) * 2004-04-14 2005-10-27 Pfizer Limited Sulphur-linked imidazole compounds for the treament of hiv
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303200A (en) * 1963-11-05 1967-02-07 American Home Prod Pyrazole-1-ethanol derivatives
GB0016787D0 (en) * 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
EP1377556B1 (en) * 2001-04-10 2007-04-04 Pfizer Limited Pyrazole derivatives for treating hiv

Also Published As

Publication number Publication date
OA12920A (en) 2006-10-13
WO2004024147A1 (en) 2004-03-25
JP2006504792A (ja) 2006-02-09
ECSP055673A (es) 2005-07-06
EP1542679A1 (en) 2005-06-22
KR20050043962A (ko) 2005-05-11
MA27435A1 (fr) 2005-07-01
GB0223354D0 (en) 2002-11-13
PL375976A1 (en) 2005-12-12
AU2003263422A1 (en) 2004-04-30
CN1681494A (zh) 2005-10-12
DE60311284T2 (de) 2007-06-21
IS7705A (is) 2005-02-21
GB0221477D0 (en) 2002-10-23
EA200500287A1 (ru) 2005-10-27
CA2496315A1 (en) 2004-03-25
DE60311284D1 (de) 2007-03-08
NO20051833L (no) 2005-06-14
MXPA05002963A (es) 2005-05-27
EP1542679B1 (en) 2007-01-17
AP2005003248A0 (en) 2005-03-31
HRP20050222A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
EA200300943A1 (ru) Производные пиразола для лечения инфекции вируса иммунодефицита человека (вич)
AR024227A1 (es) Pirimidinas inhibidoras de replicacion de hiv, un proceso para su preparacion, el uso de las mismas para la manufactura de un medicamento, composiciones farmaceuticas, y un proceso para prepararlas
BRPI0510319A (pt) inibidores da enzima integrase de hiv
EA200401437A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы для лечения вич инфекции, способ их получения (варианты), способ увеличения периода полупревращения ненуклеозидного соединения, обладающего активностью против ретровирусов, и способ получения фармацевтической композиции, обладающей специфичностью к лейкоцитам
BRPI0408767A (pt) inibidores de transcriptase reversa não-nucleosìdeos i para o tratamento de doenças mediadas pelo hiv
BR0114483A (pt) Derivado de pirazol para tratamento de doenças viróticas
DK1401826T3 (da) Pyrazolderivater som inhibitorer for HIV-revers transcriptase
ATE384714T1 (de) Pyrazolderivate
BR0314243A (pt) Derivados de 4-(3,5-dicianofenoxi)pirazolo para uso como moduladores da transcriptase reversa no tratamento da i.a hiv
BRPI0509853A (pt) compostos de imidazol ligados a enxofre para o tratamento de hiv
BR0314709A (pt) Derivados de pirazol
BRPI0510306A (pt) inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
DE60319254D1 (de) Pyrazolamide zur behandlung von hiv-infektionen
UY27035A1 (es) Derivados de imidazolona para el tratamiento de enfermedades virales
BR0314930A (pt) Derivados de pirazol e seu uso como agentes terapêuticos para doenças mediadas por hiv
CR7729A (es) Derivados de 4-(3,5-dicianofenoxi) pirazol para su uso como moduladores de transcriptasa en el tratamiento, entre otros, del vih
WO2024073497A3 (en) Small molecule degraders of hiv-1 tat protein
AP1846A (en) Pyrazole Derivatives.
ECSP034800A (es) Derivados de pirazol

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A , 5A , 6A E 7A ANUIDADES.

B08J Incorrect entry in the gazette republished [chapter 8.10 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2069 DE 31/08/2010. TEXTO CORRETO: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AOS DESPACHOS PUBLICADOS NA RPI 2069 DE 31/08/2010 E RPI 2090 DE 25/01/2011.